Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained

[1]  A. Te,et al.  Three-year outcomes after Aquablation compared to TURP: Efficacy and ejaculatory improvements sustained , 2021, European Urology.

[2]  B. Chughtai,et al.  Pooled Aquablation Results for American Men with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia in Large Prostates (60–150 cc) , 2018, Advances in Therapy.

[3]  C. Roehrborn,et al.  WATER: A Double‐Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia , 2018, The Journal of urology.

[4]  C. Roehrborn,et al.  How I do it: Balloon tamponade of prostatic fossa following Aquablation. , 2017, The Canadian journal of urology.

[5]  Arman Kahokehr,et al.  Aquablation – image‐guided robot‐assisted waterjet ablation of the prostate: initial clinical experience , 2016, BJU international.

[6]  Z. Meng,et al.  Holmium Laser Enucleation versus Transurethral Resection in Patients with Benign Prostate Hyperplasia: An Updated Systematic Review with Meta-Analysis and Trial Sequential Analysis , 2014, PloS one.

[7]  F. Bruyère,et al.  180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study. , 2014, European urology.

[8]  C. Roehrborn,et al.  The Prostatic Urethral Lift for the Treatment of Lower Urinary Tract Symptoms Associated with Prostate Enlargement Due to Benign Prostatic Hyperplasia : The L , 2014 .

[9]  H. Nelson,et al.  Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendations , 2012, Annals of Internal Medicine.

[10]  John T. Wei,et al.  Update on AUA guideline on the management of benign prostatic hyperplasia. , 2011, The Journal of urology.

[11]  R. Miano,et al.  Treatment options for benign prostatic hyperplasia in older men. , 2008, Medical science monitor : international medical journal of experimental and clinical research.

[12]  M. Naslund,et al.  Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting , 2007, International journal of clinical practice.

[13]  F. Montorsi,et al.  Safety and Tolerability of Treatment for BPH , 2006 .

[14]  Rainer Hofmann,et al.  Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. , 2006, European urology.

[15]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[16]  Mrázek,et al.  Prevalence of lower urinary tract symptoms and self‐reported diagnosed ‘benign prostatic hyperplasia’, and their effect on quality of life in a community‐based survey of men in the UK , 1999, BJU international.

[17]  Marberger,et al.  Is transurethral resection of the prostate still justified? , 1999, BJU international.

[18]  D. Neal,et al.  The effect of prostatectomy on symptom severity and quality of life. , 1996, British journal of urology.

[19]  M. Barry,et al.  THE AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA , 1992, The Journal of urology.

[20]  M. Barry,et al.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. , 1992, The Journal of urology.

[21]  C. Roehrborn,et al.  Three-Year Outcomes of the Prospective, Randomized Controlled Rezūm System Study: Convective Radiofrequency Thermal Therapy for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. , 2018, Urology.